Rockland Immunochemicals Inc.

Royersford, PA

UEI
NFKNUGEMMY18
CAGE
1T8Q8
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
321 Jones Blvd, Royersford, PA 19468, USA
Website
rockland.com
Founded
1962
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Rockland Immunochemicals Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
19-037977 guinea PIG complement (lyophilized) with diluent - 5ML Contract · 75N91019P00334 National Cancer Institute $10,005
Custom mouse ascites project (25 balb/c mice). Catalog#: CUST66 Contract · 75N91018P00511 National Cancer Institute $7,180
Polyclonal antibody production in goats Contract · HHSF223201710455A Food and Drug Administration $4,156
Systemic pre-targeted radioimmunotherapy with bispecific nanobodies for cancer treatment Contract · HHSN261201600014C National Cancer Institute $299,625
Purchase Order HHSN261201600686P Contract · HHSN261201600686P National Cancer Institute $15,084

About Rockland Immunochemicals Inc.

Rockland Immunochemicals Inc. is a global biotechnology company that manufactures research tools and antibodies for basic research, assay development, and more. They specialize in antibodies and antibody-based tools.

Rockland Immunochemicals has received one prime federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute for lyophilized guinea pig complement with diluent valued at $10,005. They have also worked as a subcontractor providing monoclonal antibodies, antibody production, and antibody delivery services to the prime contractor Leidos Biomedical Research Inc. through at least two recent federal subcontract awards. The subcontracts were to generate and provide monoclonal antibodies, select immunogens, perform differential screening of hybridoma clones, create cell banks, store hybridomas, and deliver both purified antibodies and hybridomas to the prime contractor.

Quick answers

What is Rockland Immunochemicals Inc.'s UEI?

Rockland Immunochemicals Inc.'s Unique Entity ID (UEI) in SAM.gov is NFKNUGEMMY18.

What is Rockland Immunochemicals Inc.'s CAGE code?

Rockland Immunochemicals Inc.'s CAGE code is 1T8Q8.

What is Rockland Immunochemicals Inc.'s primary NAICS code?

Rockland Immunochemicals Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).

Where is Rockland Immunochemicals Inc. located?

Rockland Immunochemicals Inc.'s physical address in SAM.gov is 321 Jones Blvd, Royersford, PA 19468, USA.

Is Rockland Immunochemicals Inc. registered in SAM.gov?

Yes. Rockland Immunochemicals Inc.'s SAM.gov registration is active through June 29, 2027.

What is Rockland Immunochemicals Inc.'s most recent federal award?

Rockland Immunochemicals Inc.'s most recent federal contract award is 19-037977 guinea PIG complement (lyophilized) with diluent - 5ML (75N91019P00334), from National Cancer Institute, on May 6, 2019.

On GovTribe

See Rockland Immunochemicals Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors